Utility of a genetic risk score to predict recurrent cardiovascular events 1 year after an acute coronary syndrome: A pooled analysis of the RISCA, PRAXY, and TRIUMPH cohorts
Tài liệu tham khảo
Lloyd-Jones, 2010, American heart association statistics C, stroke statistics S. heart disease and stroke statistics–2010 update: a report from the American heart association, Circulation, 121, e46
Mulders, 2011, Patients with premature cardiovascular disease and a positive family history for cardiovascular disease are prone to recurrent events, Int. J. Cardiol., 153, 64, 10.1016/j.ijcard.2010.08.040
Burton, 2007, Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, Nature, 447, 661, 10.1038/nature05911
Erdmann, 2009, New susceptibility locus for coronary artery disease on chromosome 3q22.3, Nat. Genet., 41, 280, 10.1038/ng.307
Gudbjartsson, 2009, Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction, Nat. Genet., 41, 342, 10.1038/ng.323
Helgadottir, 2007, A common variant on chromosome 9p21 affects the risk of myocardial infarction, Science, 316, 1491, 10.1126/science.1142842
Kathiresan, 2009, Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants, Nat. Genet., 41, 334, 10.1038/ng.327
McPherson, 2007, A common allele on chromosome 9 associated with coronary heart disease, Science, 316, 1488, 10.1126/science.1142447
Samani, 2007, Genomewide association analysis of coronary artery disease, N. Engl. J. Med., 357, 443, 10.1056/NEJMoa072366
Trégouët, 2009, Genome-wide haplotype association study identifies the slc22a3-lpal2-lpa gene cluster as a risk locus for coronary artery disease, Nat. Genet., 41, 283, 10.1038/ng.314
Schunkert, 2011, Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease, Nat. Genet., 43, 333, 10.1038/ng.784
Consortium CADCDG, 2011, A genome-wide association study in europeans and south asians identifies five new loci for coronary artery disease, Nat. Genet., 43, 339, 10.1038/ng.782
Brautbar, 2009, Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the atherosclerosis risk in communities study, Circ. Cardiovasc. Genet., 2, 279, 10.1161/CIRCGENETICS.108.817338
Humphries, 2007, Candidate gene genotypes, along with conventional risk factor assessment, improve estimation of coronary heart disease risk in healthy uk men, Clin. Chem., 53, 8, 10.1373/clinchem.2006.074591
Junyent, 2010, A composite scoring of genotypes discriminates coronary heart disease risk beyond conventional risk factors in the boston puerto rican health study, Nutr. Metabolism Cardiovasc. Dis., 20, 157, 10.1016/j.numecd.2009.03.016
Kathiresan, 2008, Polymorphisms associated with cholesterol and risk of cardiovascular events, N. Engl. J. Med., 358, 1240, 10.1056/NEJMoa0706728
Morrison, 2007, Prediction of coronary heart disease risk using a genetic risk score: the atherosclerosis risk in communities study, Am. J. Epidemiol., 166, 28, 10.1093/aje/kwm060
Paynter, 2009, Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3, Ann. Intern. Med., 150, 65, 10.7326/0003-4819-150-2-200901200-00003
Paynter, 2010, Association between a literature-based genetic risk score and cardiovascular events in women, JAMA:J. Am. Med. Assoc., 303, 631, 10.1001/jama.2010.119
Talmud, 2008, Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of chd in healthy middle-aged men, Clin. Chem., 54, 467, 10.1373/clinchem.2007.095489
Trichopoulou, 2008, Genetic predisposition, nongenetic risk factors, and coronary infarct, Archives Intern. Med., 168, 891, 10.1001/archinte.168.8.891
Yamada, 2002, Prediction of the risk of myocardial infarction from polymorphisms in candidate genes, N. Engl. J. Med., 347, 1916, 10.1056/NEJMoa021445
Buysschaert, 2010, A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: the grace genetics study, Eur. heart J., 31, 1132, 10.1093/eurheartj/ehq053
Wauters, 2013, Influence of 23 coronary artery disease variants on recurrent myocardial infarction or cardiac death: the grace genetics study, Eur. heart J., 34, 993, 10.1093/eurheartj/ehs389
Mega, 2015, Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials, Lancet, 385, 2264, 10.1016/S0140-6736(14)61730-X
Bogaty, 2008, Clinical utility of c-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The risca (recurrence and inflammation in the acute coronary syndromes) study, J. Am. Coll. Cardiol., 51, 2339, 10.1016/j.jacc.2008.03.019
Pilote, 2012, Genesis-praxy (gender and sex determinants of cardiovascular disease: from bench to beyond-premature acute coronary syndrome), Am. heart J., 163, 741, 10.1016/j.ahj.2012.01.022
Arnold, 2011, Consortium ftCOR. Translational research investigating underlying disparities in acute myocardial infarction patients' health status (triumph): design and rationale of a prospective multicenter registry, Circulation Cardiovasc. Qual. Outcomes, 4, 467, 10.1161/CIRCOUTCOMES.110.960468
Lanfear, 2011, Factors influencing patient willingness to participate in genetic research after a myocardial infarction, Genome Med., 3, 39, 10.1186/gm255
Alpert, 2000, Myocardial infarction redefined–a consensus document of the joint european society of cardiology/american college of cardiology committee for the redefinition of myocardial infarction, J. Am. Coll. Cardiol., 36, 959, 10.1016/S0735-1097(00)00804-4
Thanassoulis, 2012, A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the framingham heart study, Circ. Cardiovasc. Genet., 5, 113, 10.1161/CIRCGENETICS.111.961342
Center for Outcomes Research UoMMS. Methods and formulas used to calculate the grace risk scores for patients presenting to hospital with an acute coronary syndrome. 1998–2010:http://www.outcomes-umassmed.org/grace/files/GRACE_RiskModel_Coefficients.pdf.
Sundström, 2011, Useful tests of usefulness of new risk factors: tools for assessing reclassification and discrimination, Scand. J. Public Health, 39, 439, 10.1177/1403494810396556
Pencina, 2011, Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers, Statistics Med., 30, 11, 10.1002/sim.4085
Patel, 2014, Genetic variants at chromosome 9p21 and risk of first versus subsequent coronary heart disease events: a systematic review and meta-analysis, J. Am. Coll. Cardiol., 63, 2234, 10.1016/j.jacc.2014.01.065
Tragante, 2013, The impact of susceptibility loci for coronary artery disease on other vascular domains and recurrence risk, Eur. heart J., 34, 2896, 10.1093/eurheartj/eht222
Weijmans, 2015, Incremental value of a genetic risk score for the prediction of new vascular events in patients with clinically manifest vascular disease, Atherosclerosis, 239, 451, 10.1016/j.atherosclerosis.2015.02.008
Tikkanen, 2013, Genetic risk prediction and a 2-stage risk screening strategy for coronary heart disease, Arteriosclerosis, Thrombosis, Vasc. Biol., 33, 2261, 10.1161/ATVBAHA.112.301120
Yang, 2012, Use of functional genomics to identify candidate genes underlying human genetic association studies of vascular diseases, Arteriosclerosis, thrombosis, Vasc. Biol., 32, 216, 10.1161/ATVBAHA.111.232702
Topol, 2001, Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction, Circulation, 104, 2641, 10.1161/hc4701.100910